Recent posts

TypePostAuthorRepliesLast updated
Blog entryIndia Patent Office denies patent for prostate cancer drug sold under brand name Xtandi, generic name enzalutamide James Love09 weeks 4 days ago
Blog entry9 November 2016 - WTO TRIPS Council - WHO's intervention on the Report of the UN High-Level Panel on Access to Medicines thiru09 weeks 4 days ago
Blog entry9 November 2016 - WTO TRIPS Council - India's intervention on the Report of the UN High-Level Panel on Access to Medicines thiru09 weeks 4 days ago
Blog entry9 November 2016 - WTO TRIPS Council - Brazil's intervention on the Report of the UN High-Level Panel on Access to Medicines thiru09 weeks 5 days ago
Blog entryLancet Commission on Essential Medicines Policies publishes 74 page report, endorses delinkage of R&D costs from drug prices James Love09 weeks 6 days ago
Blog entryWHO to Colombia Minister of Health: Unaffordable drug prices are a legitimate reason for issuing a compulsory license Andrew Goldman010 weeks 12 hours ago
Blog entrySome measures that a new President and/or Congress can take to lower drug prices in the near term James Love010 weeks 5 days ago
Blog entryWTO TRIPS Council - Brazil, China, India and South Africa request discussion of the UN High-Level Panel on Access to Medicines Staff010 weeks 6 days ago
Blog entryHIV revenues and industry investments in clinical trials for HIV James Love011 weeks 3 hours ago
Blog entryRelative prices of brand and generic drugs James Love011 weeks 8 hours ago
Blog entryWashington Monthly Cover Story Highlights Petition to Lower Price of Xtandi in U.S. KEI Staff011 weeks 3 days ago
Blog entryExtending Bayh-Dole March-in rights James Love011 weeks 4 days ago
Blog entryFace time is policy: Appointment logs for USTR officials Froman, Holleyman and Punke, through July 2016 James Love011 weeks 5 days ago
Blog entry56 NGOs ask US Government enable export of low cost generic versions Xtandi to developing countries Zack Struver012 weeks 8 hours ago
Blog entryKite Pharma Press Releases & News Stories Related to Relationship with National Cancer Institute Zack Struver012 weeks 4 days ago
Page2016: KEI comments on NIH proposal for exclusive licenses to Dedalus Pharma, LLC Diane Singhroy012 weeks 4 days ago
Blog entry17 October 2016: USTR Ambassador Michael Froman's reflections on the United Nations High-Level Panel on Access to Medicines thiru012 weeks 5 days ago
Blog entryKite Pharma Uses CRADAs to Conduct Important Clinical Research on New Cancer Treatments Zack Struver012 weeks 6 days ago
Blog entry5 October 2016: Statement of Knowledge Ecology International at inaugural Marrakesh Treaty Assembly thiru014 weeks 3 days ago
Blog entryKEI statement at WIPO GA 2013 on the Inter-governmental Committee (IGC) on genetic resources, traditional knowledge James Love014 weeks 4 days ago
Blog entryWIPO GA 2016: Statement by India on behalf of Asia Pacific Group - Report on the IGC thiru014 weeks 4 days ago
Blog entryWIPO General Assembly 2016: Statement of Knowledge Ecology International on the Report of the SCCR thiru014 weeks 5 days ago
Blog entryWIPO General Assembly 2016: Opening Statement of Knowledge Ecology International KEI Staff014 weeks 6 days ago
Blog entryGeneral Assembly 2016 - Opening Statement of Bangladesh on behalf of the LDC Group thiru014 weeks 6 days ago
Blog entryDeciphering consultant speak: Romulus, a case study thiru015 weeks 13 hours ago